Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Sundan

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Ejhaem|January 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and DexamethasoneTobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patientsØystein Sandanger, Liv Ryan, Janne Bohnhorst, et al.
JBMR Plus|January 21, 2020
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on BoneMarita Westhrin, Toril Holien, Muhammad Zahoor, et al.
Journal of Hematology & Oncology|February 21, 2018
Artesunate shows potent anti-tumor activity in B-cell lymphomaThea Kristin Våtsveen, Marit Renée Myhre, Chloé Beate Steen, et al.
Leukemia|June 1, 2022
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergenceKristine Misund, Davine Hofste Op Bruinink, Eivind Coward, et al.
Iscience|January 10, 2022
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cellsKristin Roseth Aass, Robin Mjelle, Martin H Kastnes, et al.
Journal for Immunotherapy of Cancer|May 16, 2020
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockadeRui Yang, Samah Elsaadi, Kristine Misund, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Ejhaem|January 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and DexamethasoneTobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patientsØystein Sandanger, Liv Ryan, Janne Bohnhorst, et al.
JBMR Plus|January 21, 2020
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on BoneMarita Westhrin, Toril Holien, Muhammad Zahoor, et al.
Journal of Hematology & Oncology|February 21, 2018
Artesunate shows potent anti-tumor activity in B-cell lymphomaThea Kristin Våtsveen, Marit Renée Myhre, Chloé Beate Steen, et al.
Leukemia|June 1, 2022
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergenceKristine Misund, Davine Hofste Op Bruinink, Eivind Coward, et al.
Iscience|January 10, 2022
Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cellsKristin Roseth Aass, Robin Mjelle, Martin H Kastnes, et al.
Journal for Immunotherapy of Cancer|May 16, 2020
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockadeRui Yang, Samah Elsaadi, Kristine Misund, et al.
Pageof 8